Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310000, China.
Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou, 310000, China.
Acta Pharmacol Sin. 2024 Jun;45(6):1214-1223. doi: 10.1038/s41401-024-01248-1. Epub 2024 Mar 11.
CD80 is a transmembrane glycoprotein belonging to the B7 family, which has emerged as a crucial molecule in T cell modulation via the CD28 or CTLA4 axes. CD80-involved regulation of immune balance is a finely tuned process and it is important to elucidate the underlying mechanism for regulating CD80 function. In this study we investigated the post-translational modification of CD80 and its biological relevance. By using a metabolic labeling strategy, we found that CD80 was S-palmitoylated on multiple cysteine residues (Cys261/262/266/271) in both the transmembrane and the cytoplasmic regions. We further identified zDHHC20 as a bona fide palmitoyl-transferase determining the S-palmitoylation level of CD80. We demonstrated that S-palmitoylation protected CD80 protein from ubiquitination degradation, regulating the protein stability, and ensured its accurate plasma membrane localization. The palmitoylation-deficient mutant (4CS) CD80 disrupted these functions, ultimately resulting in the loss of its costimulatory function upon T cell activation. Taken together, our results describe a new post-translational modification of CD80 by S-palmitoylation as a novel mechanism for the regulation of CD80 upon T cell activation.
CD80 是一种跨膜糖蛋白,属于 B7 家族,它作为 T 细胞调节中的关键分子,通过 CD28 或 CTLA4 轴发挥作用。CD80 参与免疫平衡的调节是一个精细调控的过程,阐明调节 CD80 功能的潜在机制非常重要。在本研究中,我们研究了 CD80 的翻译后修饰及其生物学相关性。通过使用代谢标记策略,我们发现 CD80 在跨膜和细胞质区域的多个半胱氨酸残基(Cys261/262/266/271)上发生 S-棕榈酰化。我们进一步鉴定出 zDHHC20 是决定 CD80 S-棕榈酰化水平的真正的棕榈酰转移酶。我们证明 S-棕榈酰化可保护 CD80 蛋白免受泛素化降解,调节其蛋白稳定性,并确保其准确的质膜定位。棕榈酰化缺陷突变体(4CS)CD80 破坏了这些功能,最终导致其在 T 细胞激活时丧失共刺激功能。总之,我们的研究结果描述了 CD80 通过 S-棕榈酰化的一种新的翻译后修饰,作为 T 细胞激活时调节 CD80 的一种新机制。